ISSN:

Journal Home

Neuropsychopharmacology Reports Q2 Unclaimed

John Wiley & Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neuropsychopharmacology Reports is a journal indexed in SJR in Pharmacology and Psychiatry and Mental Health with an H index of 22. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2052 €. The scope of the journal is focused on psychopharmacology, neurology, neuropsychology, psychiatry, pharmacology. It has an SJR impact factor of 0,66 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,66.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Clinical Psychology (Q2) Pharmacology (Q2) Pharmacology (medical) (Q2) Pharmacology (medical) (Q2) Psychiatry and Mental Health (Q2)

Price

2052 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,66

SJR Impact factor

22

H Index

105

Total Docs (Last Year)

201

Total Docs (3 years)

3867

Total Refs

480

Total Cites (3 years)

199

Citable Docs (3 years)

2.4

Cites/Doc (2 years)

36.83

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Drug Safety - Case Reports Q2
Cancer Biology and Therapy Q2
Journal of Pharmacological Sciences Q2
AIDS Research and Therapy Q2
Pharmacological Reports Q2

Compare this journals

Aims and Scope

Psychopharmacology Neurology Neuropsychology Psychiatry Pharmacology